動態

• 

  Mary Grace N. Tamio   shared news

  在 February 26 2024 at 07:27 PM 已編輯 public

  Optimized New Shengmai Powder modulation of cAMP/Rap1A signaling pathway attenuates myocardial fibrosis in heart failure
  
  #myocardialfibrosis #heartfailure #journals #articles
  
  More info | ⬇️

  

  Optimized New Shengmai Powder modulation of cAMP/Rap1A signaling pathway attenuates myocardial fibrosis in heart failure

  Optimized New Shengmai Powder (ONSMP) is a traditional Chinese medicine formula with significant anti-heart failure and my...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享
• 

  Mary Grace N. Tamio   shared news

  在 March 25 2023 at 06:57 PM 已編輯 public

  Cardiovascular involvement in Erdheim–Chester diseases is associated with myocardial fibrosis and atrial dysfunction
  
  #cardiovasculardisease #myocardialfibrosis #atrialdysfunction #journals #articles
  
  More info | ⬇️

  

  Cardiovascular involvement in Erdheim–Chester diseases is associated with myocardial fibrosis and atrial dysfunction

  Erdheim–Chester disease (ECD) is a rare multisystem histiocytosis, whose cardiovascular involvement has not been sys...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享
• 

  Mary Grace N. Tamio   shared news

  在 May 05 2021 at 05:58 PM 已編輯 public

  Integrating Measures of Myocardial Fibrosis in the Transition from Hypertensive Heart Disease to Heart Failure
  
  #myocardialfibrosis #heartdisease #heartfailure #journals
  
  For more information | ⬇️
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享